scholarly article | Q13442814 |
P2093 | author name string | A. L. Bisno | |
P2860 | cites work | Evidence for Quantitative Variability of Bacterial Opsonic Requirements | Q34464286 |
Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A streptococci. I. A typical behavior of some human and rabbit bloods | Q36263986 | ||
Studies on the pathogenicity of group A streptococci. II. The antiphagocytic effects of the M protein and the capsular gel | Q36264299 | ||
Pneumococcal type-associated variability in alternate complement pathway activation | Q39063946 | ||
Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid | Q40880870 | ||
Activation of the alternative complement pathway by a streptococcal lipoteichoic acid | Q40911951 | ||
Role of Complement in Host Defense against Experimental Disseminated Candidiasis | Q40924091 | ||
Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein | Q42940669 | ||
Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway | Q42940715 | ||
NATURAL RESISTANCE OF GERM-FREE MICE AND COLOSTRUM-DEPRIVED PIGLETS TO GROUP A STREPTOCOCCI | Q44213982 | ||
C3 shunt activation in human serum chelated with EGTA | Q69377264 | ||
Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid | Q28363587 | ||
Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall | Q34075604 | ||
Activation of the alternative complement pathway by Haemophilus influenzae type B | Q34431568 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microbiology | Q7193 |
immunology | Q101929 | ||
complement activation | Q14864930 | ||
P304 | page(s) | 1172-1176 | |
P577 | publication date | 1979-12-01 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Alternate complement pathway activation by group A streptococci: role of M-protein | |
P478 | volume | 26 |
Q37042901 | A plasmid-encoded outer membrane protein, TraT, enhances resistance of Escherichia coli to phagocytosis |
Q70312851 | Activation of the alternate complement pathway by peptidoglycan of Actinomyces viscosus, a potentially pathogenic oral bacterium |
Q68906065 | Albumin bound to the surface of M protein-positive streptococci increased their phagocytosis by human polymorphonuclear leukocytes in the absence of complement and bactericidal antibodies |
Q40680963 | Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci |
Q33558301 | Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. |
Q41991832 | Bacteriophage control of antiphagocytic determinants in group A streptococci |
Q72772010 | Binding ability of complement receptor CR1 to C3 bound on the surface of M+ group A streptococci |
Q67974091 | Chemotactic response of equine polymorphonuclear leucocytes to Streptococcus equi |
Q35273594 | Clinical and molecular characteristics of invasive and noninvasive skin and soft tissue infections caused by group A Streptococcus |
Q42936910 | Common protective antigens of group A streptococcal M proteins masked by fibrinogen |
Q37055410 | Common themes in microbial pathogenicity |
Q37188413 | Comparison of epidemic and endemic group G streptococci by restriction enzyme analysis |
Q36302638 | Complement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes - An in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions |
Q40737570 | Complement-related proteins in pathogenic organisms |
Q36706284 | Cooperative plasminogen recruitment to the surface of Streptococcus canis via M protein and enolase enhances bacterial survival |
Q36350126 | Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3 |
Q33374391 | Determination of the mimic epitope of the M-like protein adhesin in swine Streptococcus equi subsp. zooepidemicus |
Q37024048 | Expression of M type 12 protein by a group A streptococcus exhibits phaselike variation: evidence for coregulation of colony opacity determinants and M protein |
Q35381699 | Expression of the Arp protein, a member of the M protein family, is not sufficient to inhibit phagocytosis of Streptococcus pyogenes |
Q51784676 | Food-Borne Outbreak of Group G Streptococcal Pharyngitis in a School Dormitory in Osaka, Japan. |
Q35777766 | Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding Protein |
Q36341947 | Human neutrophil chemotactic response to group A streptococci: bacteria-mediated interference with complement-derived chemotactic factors |
Q36444661 | Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages |
Q37000013 | Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. |
Q35111097 | Influence of surface modulations by enzymes and monoclonal antibodies on alternative complement pathway activation by Yersinia enterocolitica |
Q40374991 | Inhibition of C3 deposition on Streptococcus equi subsp. equi by M protein: a mechanism for survival in equine blood. |
Q40155215 | Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein |
Q34182263 | Interaction between M-like protein and macrophage thioredoxin facilitates antiphagocytosis for Streptococcus equi ssp. zooepidemicus |
Q33752194 | M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H |
Q30452551 | M proteins of group C streptococci isolated from patients with acute pharyngitis |
Q34261814 | Microarray analysis of the effect of Streptococcus equi subsp. zooepidemicus M-like protein in infecting porcine pulmonary alveolar macrophage |
Q37027498 | Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls |
Q39534301 | Molecular aspects of the phagocytosis resistance of group A streptococci |
Q34188734 | Molecular basis of group A streptococcal virulence |
Q34257502 | Multiple ligand binding sites on domain seven of human complement factor H. |
Q40615120 | Phagocytosis and killing of Streptococcus pyogenes by human alveolar macrophages. |
Q34001813 | Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. |
Q24601968 | Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin |
Q35545719 | Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia. |
Q30382858 | Streptococcal M protein: molecular design and biological behavior. |
Q40149945 | Streptococcal rheumatic carditis |
Q35780115 | Streptococcus uberis resists the bactericidal action of bovine neutrophils despite the presence of bound immunoglobulin |
Q33538951 | Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope |
Q30311508 | The Jeremiah Metzger Lecture. Microbial defenses against killing by phagocytes |
Q36354665 | The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci |
Q37031198 | Unimpaired function of human phagocytes in the presence of phagocytosis-resistant group A streptococci |
Q36966384 | Virulent human strains of group G streptococci express a C5a peptidase enzyme similar to that produced by group A streptococci |
Search more.